​

Foghorn Therapeutics Ownership | Who Owns Foghorn Therapeutics?

OverviewForecastRevenueFinancialsChart

Foghorn Therapeutics Ownership Summary

Foghorn Therapeutics is owned by 13.24% institutional investors, 18.03% insiders, and 68.73% retail investors. Flagship pioneering is the largest institutional shareholder, holding 20.12% of FHTX shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 4.73% of its assets in Foghorn Therapeutics shares.

FHTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockFoghorn Therapeutics13.24%18.03%68.73%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Flagship pioneering12.67M20.12%$61.98M
Fmr5.47M8.69%$26.77M
Bvf inc/il5.30M8.42%$25.93M
Raymond james & associates2.34M5.51%$13.45M
Deerfield management company, l.p. (series c)3.26M5.17%$15.92M
Raymond james financial2.46M3.91%$12.04M
Blackrock funding, inc. /de2.35M3.73%$12.69M
Blackrock1.55M3.64%$8.89M
Vanguard group1.93M3.06%$10.42M
Euclidean capital1.57M2.50%$7.70M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Flagship pioneering12.67M21.18%$61.98M
Euclidean capital1.57M3.23%$7.70M
Bvf inc/il5.30M1.05%$25.93M
Birchview capital, lp281.73K1.04%$1.38M
Deerfield management company, l.p. (series c)3.26M0.24%$15.92M
Brummer multi-strategy ab4.71K0.15%$25.42K
Dafna capital management126.86K0.15%$620.34K
Sio capital management122.89K0.15%$600.93K
Siren720.72K0.14%$3.52M
Artal group720.72K0.11%$4.14M

Top Buyers

HolderShares% AssetsChange
Blackrock1.55M0.00%230.70K
Renaissance297.74K0.00%179.50K
Readystate asset management lp161.14K0.03%161.14K
Woodline partners lp108.60K0.00%108.60K
Raymond james & associates2.34M0.01%107.97K

Top Sellers

HolderShares% AssetsChange
Driehaus capital management---568.47K
Perceptive advisors---544.00K
Alphabet---500.90K
Point72 asset management371.03K0.00%-297.69K
Dafna capital management126.86K0.15%-173.59K

New Positions

HolderShares% AssetsChangeValue
Readystate asset management lp161.14K0.03%161.14K$787.98K
Woodline partners lp108.60K0.00%108.60K$531.03K
Diadema partners lp50.00K0.06%50.00K$244.50K
Occudo quantitative strategies lp11.87K0.01%11.87K$58.06K
Persistent asset partners11.44K0.04%11.44K$55.95K

Sold Out

HolderChange
Ifp advisors-2.00
Zurcher kantonalbank (zurich cantonalbank)-2.00
Nelson, van denburg & campbell wealth management group-3.00
Capital performance advisors llp-14.00
Visionpoint advisory group-210.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202549-43.68%8,344,333-79.60%130.31%23-48.89%14-33.33%
Sep 30, 202549-33.78%13,088,757-67.93%200.49%21-52.27%1416.67%
Jun 30, 202578-10.34%40,954,5985.44%651.70%4528.57%14-51.72%
Mar 31, 2025883.53%40,415,6380.43%641.56%35-27.08%29163.64%
Dec 31, 202436-55.00%7,752,816-80.62%120.30%22-46.34%2-89.47%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl O2.62M4.73%-
Fidelity Growth Compy Commingled Pl S2.71M4.63%2.39K
Fidelity Growth Company Fund1.84M3.13%-10.35K
Vanguard Total Stock Mkt Idx Inv1.03M1.75%-
Vanguard US Total Market Shares ETF962.18K1.73%-
iShares Russell 2000 ETF771.18K1.32%349.67K
Fidelity Growth Company K6513.88K0.88%-4.34K
Vanguard Institutional Extnd Mkt Idx Tr364.40K0.62%-
Fidelity Small Cap Index341.22K0.58%5.34K
Fidelity Series Growth Company327.31K0.56%-2.20K

Recent Insider Transactions

DateNameRoleActivityValue
Sep 23, 2024Costa Carlos Chief People OfficerSell$8.72K
Sep 20, 2024Costa Carlos Chief People OfficerSell$358.99K
Sep 18, 2024Costa Carlos Chief People OfficerSell$116.32K
Sep 16, 2024Costa Carlos Chief People OfficerSell$4.00K
Sep 17, 2024Costa Carlos Chief People OfficerSell$103.13K

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q4--
2025 Q2--
2025 Q1--
2024 Q4--

FHTX Ownership FAQ

Who Owns Foghorn Therapeutics?

Foghorn Therapeutics shareholders are primarily institutional investors at 13.24%, followed by 18.03% insiders and 68.73% retail investors. The average institutional ownership in Foghorn Therapeutics's industry, Biotech Stocks , is 381.47%, which Foghorn Therapeutics falls below.

Who owns the most shares of Foghorn Therapeutics?

Foghorn Therapeutics’s largest shareholders are Flagship pioneering (12.67M shares, 20.12%), Fmr (5.47M shares, 8.69%), and Bvf inc/il (5.3M shares, 8.42%). Together, they hold 37.24% of Foghorn Therapeutics’s total shares outstanding.

Does Blackrock own Foghorn Therapeutics?

Yes, BlackRock owns 3.64% of Foghorn Therapeutics, totaling 1.55M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.89M$. In the last quarter, BlackRock increased its holdings by 230.7K shares, a 17.54% change.

Who is Foghorn Therapeutics’s biggest shareholder by percentage of total assets invested?

Flagship pioneering is Foghorn Therapeutics’s biggest shareholder by percentage of total assets invested, with 21.18% of its assets in 12.67M Foghorn Therapeutics shares, valued at 61.98M$.

Who is the top mutual fund holder of Foghorn Therapeutics shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Foghorn Therapeutics shares, with 4.73% of its total shares outstanding invested in 2.62M Foghorn Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools